Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02657993 · ClinicalTrials.gov registry record · NA

Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence

A NA study of Breast Neoplasms and Musculoskeletal Pain, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
191
Enrollment target
1
Study location

NCT02657993 is a NA study of Breast Neoplasms and Musculoskeletal Pain that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 191 participants, below the 567-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02657993, a NA study of Breast Neoplasms and Musculoskeletal Pain, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
191 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether hypnosis is efficacious in reducing musculoskeletal pain in breast cancer survivors taking aromatase inhibitors, and by doing so, whether hypnosis can help survivors to be more adherent to their medication regimen.

Conditions Studied

Breast Neoplasms Musculoskeletal Pain

Interventions

  • BEHAVIORAL Attention Control
  • BEHAVIORAL Hypnosis

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 191 participants
Start Date 2016-03
Est. Completion 2021-03-18
Phase NA

Sponsor

Icahn School of Medicine at Mount Sinai

708 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02657993

The ClinicalTrials.gov registry entry for NCT02657993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 191 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 567-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (66% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.

NCT02657993 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02657993 about?

NCT02657993 is a clinical study titled "Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence". The purpose of this study is to determine whether hypnosis is efficacious in reducing musculoskeletal pain in breast cancer survivors taking aromatase inhibitors, and by doing so, whether hypnosis can help survivors to be more adherent to their medication regimen.

What is the current status of trial NCT02657993?

This trial is currently completed. It is a NA study. The enrollment target is 191 participants. The study started on 2016-03. Estimated completion is 2021-03-18.

What conditions does trial NCT02657993 study?

This clinical trial studies the following conditions: Breast Neoplasms, Musculoskeletal Pain.

What interventions are being tested in trial NCT02657993?

The interventions under investigation include: Attention Control (BEHAVIORAL), Hypnosis (BEHAVIORAL).

Who is sponsoring clinical trial NCT02657993?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02657993 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Neoplasms

All registered trials for this condition

Musculoskeletal Pain

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.